4//SEC Filing
Nau Jeffrey 4
Accession 0001209191-21-061371
CIK 0001720725other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 4:41 PM ET
Size
8.1 KB
Accession
0001209191-21-061371
Insider Transaction Report
Form 4
Nau Jeffrey
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-10-21−50,000→ 434,774 totalExercise: $1.02Exp: 2027-11-10→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2021-10-21$1.02/sh+50,000$51,000→ 110,898 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]These shares are held by the Reporting Person's spouse.
- [F2]This option was granted on November 10, 2017 under the Oyster Point Pharma, Inc. 2016 Equity Incentive Plan. One forty-eighth of the total number of shares subject to the original option vested on December 1, 2017, and one forty-eighth of the remaining shares vested, and continue to vest, monthly thereafter, subject to continued service to the Issuer through each such vesting date. The award is subject to vesting acceleration under certain circumstances.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001791159
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 4:41 PM ET
- Size
- 8.1 KB